ADiTx Inc (ADTX): Is there Rs meeting why every board peop...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	15
Posts	2142
Boards Moderated	0
Alias Born	04/05/2017

Pt3

Re: None

Sunday, 07/10/2022 11:04:32 AM

Sunday, July 10, 2022 11:04:32 AM

Is there Rs meeting why every board people asking Rs meeting

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADTX News

Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:24:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:15:45 PM
Evofem Biosciences Announces Financial Results for the First Quarter of 2024 • PR Newswire (US) • 05/15/2024 10:50:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:15:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:15:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:15:44 PM
CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 06:14:00 PM
Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules • Business Wire • 05/03/2024 01:00:00 PM
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) • Business Wire • 04/02/2024 12:30:00 PM
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 • PR Newswire (US) • 03/27/2024 12:36:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:51:37 PM
For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy • PR Newswire (US) • 03/07/2024 12:54:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/04/2024 10:27:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:24:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:01:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:01:59 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/22/2024 10:21:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:30:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:30:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:30:52 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:26:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:31:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:30:11 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/02/2024 09:28:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:26:13 PM

More ADTX News

InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover